West Nile Virus Central Nervous System Infection in Patients Treated With Rituximab: Implications for Diagnosis and Prognosis, With a Review of Literature.

Morjaria, Sejal; Arguello, Esther; Taur, Ying; Sepkowitz, Kent; Hatzoglou, Vaios; Nemade, Ajay; Rosenblum, Marc; Cavalcanti, Marcela S; Palomba, M Lia; Kaltsas, Anna

Morjaria, Sejal; Arguello, Esther; Taur, Ying; Sepkowitz, Kent; Hatzoglou, Vaios; Nemade, Ajay; Rosenblum, Marc; Cavalcanti, Marcela S; Palomba, M Lia; Kaltsas, Anna.

Afiliação

Morjaria S; Infectious Disease Service, Department of Medicine.
Arguello E; Infectious Disease Service, Department of Medicine.
Taur Y; Infectious Disease Service, Department of Medicine.
Sepkowitz K; Infectious Disease Service, Department of Medicine.
Hatzoglou V; Neuroradiology Service, Department of Radiology.
Nemade A; Neuroradiology Service, Department of Radiology.
Rosenblum M; Departments of Pathology.
Cavalcanti MS; Departments of Pathology.
Palomba ML; Immunology and Medicine , Memorial Sloan-Kettering Cancer Center , New York, New York.
Kaltsas A; Infectious Disease Service, Department of Medicine.

Open Forum Infect Dis ; 2(4): ofv136, 2015 Dec.

Article em En | MEDLINE | ID: mdl-26576450

Palavras-chave

West Nile virus; immunocompromised host; lymphoma; molecular testing; rituximab

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies Idioma: En Revista: Open Forum Infect Dis Ano de publicação: 2015 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google